Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now indicates that the ClinicalTrials.gov data ingest will be modernized in June 2025, and it has updated the status from 'Recruiting' to 'Active, not recruiting'.
    Difference
    7%
    Check dated 2025-05-30T04:44:11.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    1.0%
    Check dated 2025-05-23T02:04:31.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The date has been updated from April 25, 2025, to May 1, 2025.
    Difference
    0.7%
    Check dated 2025-05-08T13:46:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and changed the date from 2024-11-01 to 2025-04-25.
    Difference
    1%
    Check dated 2025-05-01T06:18:01.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. Additionally, a phrase has been removed, which may affect the clarity of the content.
    Difference
    1.0%
    Check dated 2025-04-16T20:35:33.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T14:37:52.000Z thumbnail image

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.